Pear Therapeutics- Warrants (01/12/2026) OverviewPear Therapeutics- Warrants (01/12/2026) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for PEARW.
Quarterly EBIT
-$29.16M
↑ 14.82% YoY
As of Dec 31, 2022
Annual EBIT (TTM)
-$123.35M
↓ 241.38% YoY
Trailing 12 months ending Dec 31, 2022